Cargando…
Cancer-associated TERT promoter mutations abrogate telomerase silencing
Mutations in the human telomerase reverse transcriptase (TERT) promoter are the most frequent non-coding mutations in cancer, but their molecular mechanism in tumorigenesis has not been established. We used genome editing of human pluripotent stem cells with physiological telomerase expression to el...
Autores principales: | Chiba, Kunitoshi, Johnson, Joshua Z, Vogan, Jacob M, Wagner, Tina, Boyle, John M, Hockemeyer, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507476/ https://www.ncbi.nlm.nih.gov/pubmed/26194807 http://dx.doi.org/10.7554/eLife.07918 |
Ejemplares similares
-
Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC
por: Khattar, Ekta, et al.
Publicado: (2017) -
Taking the brakes off telomerase
por: Naxerova, Kamila, et al.
Publicado: (2015) -
Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations
por: Tornesello, Maria Lina, et al.
Publicado: (2023) -
Upregulation of neurovascular communication through filamin abrogation promotes ectopic periventricular neurogenesis
por: Houlihan, Shauna L, et al.
Publicado: (2016) -
Chromatin dynamics and the role of G9a in gene regulation and enhancer silencing during early mouse development
por: Zylicz, Jan J, et al.
Publicado: (2015)